
Wadiz sets out to export ‘K-funding' as Asia's answer to Kickstarter
From K-beauty to smart appliances, CEO sees growing demand for Asian innovation—and aims to be the platform that delivers
When Shin Hye-sung left the state-run Korea Development Bank in 2012 to start a crowdfunding platform, he wasn't chasing unicorns. He was looking out for overlooked potential: early-stage entrepreneurs with good ideas but few backers.
That vision became Wadiz, now South Korea's largest crowdfunding platform, with 6.8 million users and more than 83,000 campaigns raising a combined 1.3 trillion won ($928 million).
After more than a decade helping domestic startups raise capital from fans and early adopters, Shin says it's time to take the model global — not by opening foreign offices, but by riding the wave of artificial intelligence.
'We're not becoming a global company by planting flags,' he said. 'We've always been a cross-border platform. The real shift is just opening up what we already do to the world.'
To Shin, Wadiz was never just a fundraising site. After five years of funding Korea's industrial backbone at KDB, he came away with a sobering conclusion: The country couldn't rely on a handful of conglomerates to power its future.
'When I started Wadiz 13 years ago, I did so thinking Korea had no future if things didn't change,' he said.
That outlook has since gained urgency. Growth has stalled across Korea's key sectors, with the economy projected to expand by less than 1 percent this year.
In response, Shin built a system he hoped could serve as an alternative. What began as a modest platform to test and discover creative product ideas has grown into a full-stack ecosystem for startup growth — with a permanent storefront, Wadiz X, and a venture arm, Wadiz Partners.
AI clears way to world
Wadiz's international ambitions had long been constrained by a key hurdle: screening campaigns across languages and legal systems — a critical task for a platform that, as a financial service, must vet every project to manage risk and protect backers.
The AI boom was the game changer, Shin says. Generative AI now drives much of the platform's internal operations, from document review to multilingual localization and real-time policy updates.
'The technology lets us do things at scale that would have required human teams in every market,' he said. 'AI didn't just solve the language barrier. It destroyed every barrier.'
On May 21, Wadiz will officially go global, opening its platform to users in more than 200 countries. Creators will be able to select their target markets, with initial focus on North America. English will be the first supported language, with others to follow.
Even before the launch, interest from abroad was evident, with users around the world browsing campaigns, even if they couldn't contribute, said Shin.
'The world is hungry for new ideas coming out of Korea — especially in content, beauty and food. That's exactly where we're focusing with this launch.'
Global, but Korea-based
While the launch marks a major step, Shin says the overseas push has always been part of the plan.
Wadiz's slow-delivery model — where products are manufactured only after campaigns are funded — differs from traditional e-commerce and sidesteps the need for warehousing or logistics infrastructure.
'We're not here to be another Kickstarter,' Shin said, referring to the US-based crowdfunding giant. 'We're here to show that global doesn't have to mean American —and that a Korea-based platform can do it better.'
That's why Shin, who could have built a VC fund or accelerator, chose instead to build a platform that connects creators and supporters directly. In Korea's saturated, demanding market, he argues, only constant refinement ensures survival.
'The scale might not be significant yet, but I assure you, the service quality is already world-class,' he said.
K-funding as export item
Alongside its global rollout, Wadiz is working to bring in more international creators. Foreign campaigns currently make up just 10 percent of listings — mostly from Japan and China — but Shin expects that share to grow fast.
'Visitor data shows strong demand for products from across Asia—not just Korea,' he said. 'We plan to scale sourcing from China and Japan and open more offerings to worldwide.'
China, in particular, is gaining traction for a surge in high-end tech and smart appliances. In 2021, Shanghai-listed Roborock hit 2,000 percent of its funding goal on Wadiz within an hour — and reached 6,300 percent by day 15.
Looking ahead, Wadiz is preparing to export what Shin calls 'K-funding' — a turnkey version of its platform, complete with training programs, operational policies and technical infrastructure tailored for emerging markets.
Governments in Southeast Asia, including Thailand, have expressed interest in importing the model to foster local entrepreneurship. What resonates most, Shin says, is how Wadiz connects grassroots crowdfunding with institutional capital —bridging a gap many economies still face, particularly in under-scaled consumer sectors.
In Korea, Wadiz has shaped that pipeline somewhat. Startups that perform well on the platform can secure follow-on investment from Wadiz Partners, either directly or through joint funds backed by corporations and government programs. The subsidiary currently manages about 20 billion won in assets.
'While tech startups often attract VC funding, brand-focused businesses are frequently overlooked,' Shin said. 'It's meaningful that we focus on stably backing early-stage companies in lifestyle and consumer goods.'
Ultimately, Shin sees Wadiz not just as a tool for startup growth, but as a model to fortify economic resilience
'Societies can't thrive by supporting only the giants,' he said. 'They need ecosystems where new businesses can emerge, stumble, and try again.'
That, he argues, is where Korea lags behind more advanced economies like the US where a strong entrepreneurial middle class allows new challengers to scale naturally.
'Korea is in crisis today because we haven't built that middle layer of businesses,' he said. 'Strengthening this rung of the corporate ladder is essential to keeping the economy moving.'
As Korea enters an era of low growth, Shin sees Wadiz as part of the answer — not by clinging to a 'Made in Korea' label, but by building digital trade routes that connect innovation across borders.
'It's no longer just about selling Korean goods or linking buyers and sellers,' he said. 'Our expansion is about creating an 'online Silk Road' — a cross-border infrastructure to help startups grow globally — anchored in Korea.'
The Top 100 Global Innovators series spotlights the trailblazers shaping Korea's futur e across a range of industries — from bold entrepreneurs and tech pioneers to research leaders — whose innovations are making a global impact beyond Korea. More than a celebration of success, the series offers a deeper exploration of the ideas, breakthroughs and strategies driving their achievements. — Ed.
jwc@heraldcorp.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
![[Bio USA] SK Biopharmaceuticals CEO highlights resilience, open innovation amid global shifts](/_next/image?url=https%3A%2F%2Fwimg.heraldcorp.com%2Fnews%2Fcms%2F2025%2F06%2F22%2Fnews-p.v1.20250622.6f347ba79b0f48699e57a8849a11dca7_T1.jpg&w=3840&q=100)
![[Bio USA] SK Biopharmaceuticals CEO highlights resilience, open innovation amid global shifts](/_next/image?url=https%3A%2F%2Fall-logos-bucket.s3.amazonaws.com%2Fkoreaherald.com.png&w=48&q=75)
Korea Herald
8 hours ago
- Korea Herald
[Bio USA] SK Biopharmaceuticals CEO highlights resilience, open innovation amid global shifts
Korea Herald correspondent BOSTON — SK Biopharmaceuticals CEO Lee Dong-hoon underscored the company's preparedness for potential US tariff changes and emphasized the critical role of open innovation in shaping the future of global pharmaceuticals. 'We've weathered volatility in our share price over the past year, but the impact of potential price cuts has been minimal,' Lee said Thursday during a press conference on the sidelines of the 2025 Bio USA. 'Our direct-to-market sales model remains fundamentally solid.' He recalled a particularly tense moment earlier this year when shifting US tariff policies posed logistical challenges. In April, the company rushed to transport finished products from Canada into the US before a new tariff deadline. 'When the final truck finally cleared customs, everyone burst into applause,' he recounted. To prevent such risks from recurring, the company now assembles finished products in Canada and ensures shipments cross the border ahead of any policy changes. Looking ahead, SK Biopharmaceuticals is evaluating Puerto Rico as a potential US-based manufacturing site, leveraging its status as a US territory and pharmaceutical hub. 'Canada is cost-effective for now, but we're preparing for every scenario,' Lee said, noting the company's tariff risk is now 'close to zero' for the year. Lee also expressed confidence in the company's long-term growth. 'We've already announced our goal to hit 1 trillion won ($728 million) in sales by 2029, and we're on track,' he said, citing consistent profitability since last year. A cornerstone of SK Biopharmaceuticals' strategy is open innovation. Instead of relying solely on internal research and development, the company is partnering with universities, biotech firms and research institutions. 'Major global pharmaceutical firms are moving away from in-house basic research, and so are we. When you can collaborate and generate results at a fraction of the cost, your possibilities expand," he explained. The CEO emphasized the importance of tapping into underutilized technologies at US universities and biotech startups to diversify the company's pipeline, moving beyond its core focus on epilepsy into areas like oncology. Artificial intelligence is another major focus area. Lee highlighted the company's work on EEG-based seizure prediction models in collaboration with European and South American partners, along with AI algorithm development trials currently underway in Korea. 'AI is no longer optional. It's essential in every part of the business,' he said. One standout partnership is with PhnyX Lab, whose AI-driven automation of clinical documentation significantly reduced paperwork. 'Even our US team, which was initially skeptical, was blown away,' Lee said, calling the shift 'Copernican' in scale for how it will reduce time and cost. The CEO also outlined plans to build a global digital platform for epilepsy patients — a space where patients and physicians can share experiences and insights. 'It's not about selling drugs,' he clarified. 'It's about collecting data to inform AI-powered marketing, drug development and clinical trial design.' The company is looking three to five years ahead, aiming to build an ecosystem where shared data drives innovation across functions. In the US, SK Biopharmaceuticals is intensifying its engagement with health care providers. Lee has personally met with dozens of physicians this year, aiming for 100 meetings, to gather insights that will shape lifecycle strategies such as patent extensions, expanded indications and new formulations like IV delivery. Meanwhile, SK Biopharmaceuticals has invested in targeted TV and YouTube campaigns for its flagship epilepsy drug, Xcopri (cenobamate). Its 'Road to Reduction' campaign drew 9.37 million views in just one month, signaling the brand's growing visibility and leadership in the epilepsy treatment market.


Korea Herald
11 hours ago
- Korea Herald
Eximbank holds workshop to strengthen Korea-Africa ties
The 30th Economic Development Cooperation Fund Workshop, hosted by the Export-Import Bank of Korea and the Ministry of Economy and Finance, commenced Tuesday, welcoming a total of 18 government officials from 10 African countries, according to the policy lender on Sunday. The EDCF is an aid loan funded by the Korean government, which offers long-term loans at a low interest rate to developing countries under an official development assistance initiative. Eximbank is in charge of running the fund. Through its annual workshop, the state-run lender invites public officials from the recipient countries, strengthening partnerships for the smooth operation of the financing aid. This year's workshop is a follow-up event to the first Korea-Africa summit held in Seoul last June, under the theme "The Future We Make Together: Shared Growth, Sustainability, and Solidarity." The 10 participating countries include Angola, Cote d'Ivoire, Egypt, Ethiopia, Ghana, Kenya, Mozambique, Rwanda, Tanzania and Uganda. 'The workshop provides an opportunity to gain a deeper understanding of EDCF's support strategy and cooperation plans for (countries in) Africa,' Dereje Wodajeneh, head of the bilateral cooperation department at Ethiopia's Ministry of Finance, said. 'It will serve as a stepping stone for strengthening exchanges and cooperation between EDCF and the African continent.' According to Eximbank, African countries account for roughly 25 percent of the total support volume for the EDCF. 'We plan to continue enhancing strategic support and cooperation with Africa, focusing on key areas such as energy transition, digital transformation and supply chain,' an official from the Eximbank said. Through the week-long event, which includes visits to the headquarters of Korea Railroad Corp. and the Global Knowledge Exchange and Development Center, the participating public officials are to broaden their understanding of Korea's official development assistance policy and the EDCF. The workshop is set to end on Wednesday.


Korea Herald
11 hours ago
- Korea Herald
HD Hyundai partners with Edison Chouest Offshore to build LNG dual-fuel container ships
Korean shipbuilding giant HD Hyundai announced Sunday that it has signed a strategic and comprehensive partnership with US-based Edison Chouest Offshore to jointly build LNG dual-fuel container ships in the United States. This initiative follows HD Hyundai's recent agreements with major US defense firms and academic institutions. The signing ceremony took place on Thursday at ECO's headquarters in New Orleans, Louisiana, attended by key officials from both companies. Under the deal, HD Hyundai and ECO plan to jointly construct medium-sized container ships at ECO's shipyards by 2028. HD Hyundai will provide support for ship design, equipment procurement and construction technology. It also plans to produce and supply ship blocks and invest in related technological assets. Both companies are exploring expanded cooperation in additional vessel types and port cranes, which are considered critical for US national security. ECO operates five shipyards across the US and manages a fleet of 300 offshore support vessels, positioning it as a major player in the OSV sector. The partnership follows a sluggish period for US shipbuilding, with domestic firms receiving orders for only three 3,600 twenty-foot equivalent unit container ships from 2022 to 2024, according to shipping market analysis firm Clarkson Research. 'The United States is a strong ally and an important business partner,' an HD Hyundai spokesperson said. 'Through this collaboration, we aim to support the revival of its shipbuilding industry and bolster its national security.'